Rv1630 - p.Glu168Lys
Drug resistance types
0 Sensitive
11 RR-TB
2 HR-TB
10 MDR-TB
7 Pre-XDR-TB
0 XDR-TB
2 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage3 | 3 |
| lineage3.1.2.1 | 1 |
| lineage2.2.2 | 9 |
| lineage4.9 | 7 |
| lineage2.2.1 | 3 |
| La1.8.1 | 1 |
| lineage4.2.1 | 2 |
| La1.7.X-unk4 | 1 |
| lineage4 | 1 |
| 2 | |
| lineage4.4.1.1 | 1 |
| lineage4.3.4.1 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 32 |
Geographic prevalence
Country level data for this variant is available for 7 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | ERR4815079 | RR-TB | lineage3 | None | SRR5341365 | Pre-XDR-TB | lineage3 | None | ERR4816717 | RR-TB | lineage3.1.2.1 | None | SRR1723426 | Pre-XDR-TB | lineage2.2.2 | cn | ERR502470 | RR-TB | lineage4.9 | None | ERR4821550 | Other | lineage2.2.1 | None | ERR502946 | Pre-XDR-TB | lineage2.2.2 | None | SRR6789628 | HR-TB | lineage4.9 | None | SRR6824594 | Pre-XDR-TB | lineage2.2.2 | cn | ERR5311077 | RR-TB | La1.8.1 | None | ERR10748430 | MDR-TB | lineage2.2.1 | None | SRR8651647 | MDR-TB | lineage2.2.2 | cn | ERR3283006 | RR-TB | lineage4.9 | None | ERR10762275 | MDR-TB | lineage4.2.1 | None | ERR3445487 | Other | La1.7.X-unk4 | None | ERR3283013 | MDR-TB | lineage4 | None | SRR1173310 | MDR-TB | None | ERR3797062 | RR-TB | lineage4.9 | None | ERR4769508 | RR-TB | lineage4.9 | None | ERR4810480 | MDR-TB | lineage2.2.2 | cn | ERR4810845 | MDR-TB | lineage2.2.2 | cn | ERR4811320 | Pre-XDR-TB | lineage2.2.2 | cn | SRR10305976 | Pre-XDR-TB | lineage2.2.2 | None | ERR4769530 | RR-TB | lineage4.9 | None | ERR4811158 | Pre-XDR-TB | lineage2.2.2 | cn | SRR14782539 | MDR-TB | lineage4.2.1 | None | SRR1173719 | HR-TB | lineage3 | None | SRR17567917 | RR-TB | lineage4.4.1.1 | None | SRR16156697 | MDR-TB | lineage2.2.1 | None | SRR16156751 | RR-TB | lineage4.9 | None | SRR16156832 | RR-TB | None | SRR22528575 | MDR-TB | lineage4.3.4.1 | None |
|---|
